SARS‐CoV‐2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project

• Published in: Andrology (Oxford) Vol. 9; no. 1; pp. 19 - 22
• Main Authors: Salonia, Andrea, Corona, Giovanni, Giwercman, Aleksander, Maggi, Mario, Minhas, Suks, Nappi, Rossella E., Sofikitis, Nikolaos, Vignozzi, Linda
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.01.2021
• Subjects: ACE2; andrology; Animals; Clinical Medicine; COVID-19; COVID-19 - metabolism; COVID-19 - mortality; COVID-19 - virology; endocrinology; Frailty - metabolism; Frailty - mortality; Frailty - virology; Health Sciences; Health Status Disparities; Host-Pathogen Interactions; Humans; Hypogonadism - metabolism; Hypogonadism - mortality; Hypogonadism - virology; Hälsovetenskap; Infections; Infectious Medicine; Infektionsmedicin; Klinisk medicin; Male; male infertility; Males; Medical and Health Sciences; Medicin och hälsovetenskap; Research Design; Risk Assessment; Risk Factors; SARS-CoV-2; SARS-CoV-2 - pathogenicity; Severe acute respiratory syndrome coronavirus 2; Sex Factors; testosterone; Testosterone - metabolism; urology; COVID-19; ACE2; SARS-CoV-2; testosterone; urology; andrology; male infertility; endocrinology

Preliminary published data depict a much greater prevalence of males with laboratory‐confirmed severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) referred for intensive care unit admission and severe sequelae in several countries. In this context, males seem to not only be more susceptible...